Carole Ho
CIK 1724605 · Chief Medical Officer · last filed 2026-06-08
Carole Ho is a Chief Medical Officer who has filed 78 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for RPRX, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$13.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.97M
4
78
-$13.21M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | Director | 13,103 | $54.87 | $719.0K | $0 | 2 | 2026-06-08 |
| DNLI | Chief Medical Officer | 242,391 | $21.66 | $5.25M | -$13.21M | 66 | 2025-08-14 |
| BEAM | Director | — | $29.03 | — | $0 | 5 | 2025-06-06 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | — | $1.54 | — | $0 | 5 | 2024-04-08 |
Recent Filings
78 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | RPRX | Grant (A) | +4,545 | $0 | EDGAR |
| 2025-08-14 | DNLI | Sell (S) | −3,743 | -$51.7K | EDGAR |
| 2025-08-07 | DNLI | Exer (M) | +44,655 | $30.4K | EDGAR |
| 2025-07-31 | RPRX | Grant (A) | +8,558 | $0 | EDGAR |
| 2025-06-06 | BEAM | Grant (A) | — | $0 | EDGAR |
| 2025-01-08 | DNLI | Sell (S) | −15,162 | -$308.3K | EDGAR |
| 2025-01-07 | DNLI | Grant (A) | +54,180 | $0 | EDGAR |
| 2024-11-27 | DNLI | Exer (M) | +17,845 | $12.1K | EDGAR |
| 2024-08-22 | DNLI | Sell (S) | −22,458 | -$549.9K | EDGAR |
| 2024-08-15 | DNLI | Sell (S) | −2,337 | -$53.5K | EDGAR |